SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-017852
Filing Date
2011-03-29
Accepted
2011-03-29 12:13:31
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 v216127_10k.htm 10-K 3773366
2 GRAPHIC pg35.jpg GRAPHIC 52601
3 v216127_ex23-1.htm EX-23.1 4649
4 v216127_ex31-1.htm EX-31.1 15585
5 v216127_ex31-2.htm EX-31.2 13790
6 v216127_ex32-1.htm EX-32.1 5540
7 v216127_ex32-2.htm EX-32.2 5749
  Complete submission text file 0001144204-11-017852.txt   3892331
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13441 | Film No.: 11717979
SIC: 2836 Biological Products, (No Diagnostic Substances)